Clinical Topics & News
News
High-deductible health plans detrimental for those with diabetes
Individuals forced to switch to high-deductible plans appear to ration care, leading to more hypo- and hyperglycemic events.
News
FDA approves new type 2 diabetes drug bexagliflozin
Another SGLT2 inhibitor has been approved for type 2 diabetes based on results from 23 clinical trials in 5,000 patients.
News
Nitrite food additives may increase risk of type 2 diabetes
Greater intake of nitrites from food additives was tied to greater risk of developing type 2 diabetes, in a French study, but some experts...
News
Diet packed with fast food found hard on the liver
“Striking” elevations in steatosis were evident among persons with obesity and diabetes who consumed fast food, in comparison with their...
News
Metformin monotherapy not always best start in type 2 diabetes
Findings suggest that at time of type 2 diabetes diagnosis some might not benefit from metformin as first-line treatment. Dual or other therapy...
News
Oramed oral insulin fails to meet goal in type 2 diabetes
Top-line results from the phase 3 trial of ORMD-0801 show that the oral insulin product didn’t meet the trial’s endpoint for change from baseline...
News
Fair access crucial for new diabetes/kidney disease drugs, say guidelines
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and...
News
PPI use in type 2 diabetes links with cardiovascular events
Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more...
News
Intermittent fasting can lead to type 2 diabetes remission
Intermittent fasting could be a paradigm shift in type 2 diabetes management, allowing patients to stop taking glucose-lowering medication.
News
ADA issues 2023 ‘Standards of Care’ for diabetes: Focus on tight BP, lipids
The new 2023 American Diabetes Association Standards of Care address management of diabetes and its complications, as well as social determinants...